First Light Asset Management, LLC
Position in RYTM — Rhythm Pharmaceuticals, Inc.
CIK 1600004
EDINA, MN
Position in RYTM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,522,487
+$1,940,356 QoQ
Shares Held
85,765
-1.6% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026First Light Asset Management, LLC holds $648,580,707 across 12 Biotechnology names. RYTM ranks #12 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | 930,289 | $123,477,258 | |||
| 2 | PVLA |
Palvella Therapeutics, Inc.
|
771,901 | $117,961,910 | |
| 3 | TWST |
Twist Bioscience Corp
|
727,933 | $74,889,747 | |
| 4 | ELVN |
Enliven Therapeutics, Inc.
|
1,360,750 | $69,058,062 | |
| 5 | 1,360,866 | $50,923,605 | |||
| 6 | EWTX |
Edgewise Therapeutics, Inc.
|
1,095,171 | $44,496,797 | |
| 7 | ANAB |
Anaptysbio, Inc
|
582,004 | $39,285,270 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
2,097,215 | $39,113,059 |
All Filings in RYTM
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,522,487 | 85,765 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,582,131 | 87,181 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $31,667,141 | 295,844 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $18,227,079 | 180,484 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||